Joel Wolf

Joel Wolf is an accomplished professional with extensive experience in quality management and clinical assurance in the pharmaceutical industry. Currently serving as the Director of Global Development Quality Management at Regeneron since 2020, Joel directs a team focused on risk-based quality management and GCP guidance for Phase 4 and real-world data/real-world evidence clinical studies. Prior to this role, Joel held the position of Executive Director and Global Head of Clinical Quality Assurance at Eisai US from 2005 to 2020, where leadership was provided for a global team and processes were developed to ensure GCP auditing and compliance. Joel holds a Bachelor's degree in Biochemistry from Brandeis University and has completed graduate-level coursework in Biochemistry, Chemistry, Nutrition, and Statistics at the University of New Hampshire.